Eugene Rusch
Chelsea, Alabama 35043 Cell: 937-***-****
acb1a1@r.postjobfree.com
Summary
Business/Technical Operations Executive
Operations executive experienced in building and managing successful global
businesses through: Strategic Planning, Operational Management, Supply
Chain Management, Financial/Budget P&L Analysis and Change Management.
Business start-up experience and thought-leader who understands the
Pharmaceutical Business and how to integrate human capital management to
achieve financial results by setting the Vision, influencing and driving
change, building competency, quality and growing employee engagement.
Demonstrated ability to manage large complex operations. Successfully
directed several major plant expansions. Lead business and technical teams
as part of due diligence for a variety of possible business acquisitions
and partnerships. Exceptional track record with FDA, EMEU and other
regulatory agencies.
Superior communication skills, vision and concept development, general
management, GMP compliance, organizational development skills, profit
maximization and cost containment, project management, supply chain
management, strategic planning and implementation.
Career Experience and Accomplishments
February 2011- Present Executive Leadership LLC
Chelsea, AL
President (Corporate Founder)
Executive Leadership LLC is a private consulting firm focused on providing
business strategy development, process improvements and executive coaching
to the Pharmaceutical/Biopharmaceutical Industry.
May to August 2013 working as a senior consultant with Quintiles,
participated in a process improvement/reliability engineering project at an
aseptic manufacturing CMO providing the following:
. Process and facility improvements
. Shop floor technical leadership
. Development of on time start tracking tool for manufacturing
. OEE program implementation planning
. Root Cause Analysis process for deviation investigations
. Pre CIP/SIP cycle readiness checklist
. Reliability process implementation and documentation for "right first
time"
April to September 2012 working as a senior consultant with Quintiles,
participated in regulatory remediation activities at a major pharmaceutical
company providing the following.
. Process and facility improvements
. Shop floor QA activities
. Development and implementation of QA check lists for shop floor real
time monitoring
. Batch Record and investigation report reviews and approvals
. SOP reviews and improvements
. Increased shop floor employee and management cGMP awareness
. Management training and mentoring
. Certification of QA personnel
. Personnel/Material flows and appropriate gowning procedures to meet
cGMP and international regulations
March 2010 - February 2011 SurModics, Inc.
Birmingham, AL
Vice President of Manufacturing (Corporate Officer)
SurModics, Inc. is an integrated Coatings, Diagnostic and Pharmaceutical
company. SurModics Pharmaceuticals is the drug delivery division with the
strategic plan of becoming a clinical and commercial manufacturing company
by 2015. Hired to assist in the strategic planning and
implementation/creation of the overall manufacturing organization. As the
head of a highly matrixed organization lead the manufacturing operations
for the Eden Prairie coatings/diagnostics and Birmingham pharmaceutical
operations. Led the creation of a manufacturing, facilities and supply
chain infrastructure to manage resources across two sites prior to the
decision to divest the Pharmaceutical operations.
. Led the start up and completion the Lakeshore Parkway manufacturing
facility that included support laboratories for testing and release of
product and facility monitoring along with pilot plant operations for
early development
. Created the organizational structure to support technical operations
that included EHS, manufacturing and supply chain functions
. Created the infrastructure and organization to manage a >200% increase
in production volumes over 5 years
. As a company officer engaged with Executive Committee and Board of
Directors to create a strategic plan for the entire corporation
. Initiated risk management and business continuity programs for the
Birmingham manufacturing operations for the purpose of a major repair and
loss of manufacturing capabilities of the facility.
March 2004 - November 2009 Alkermes, Inc.
Wilmington, Ohio
Vice President/General Manager-Manufacturing Operations
Hired by Alkermes to drive the change from a research and development based
culture to a GMP compliant commercial manufacturing operation while
containing costs and increasing profit. Alkermes, Inc had increasing
annual manufacturing revenues of $40MM - $117MM in Fiscal Years 2005-2009.
Anticipated revenues for FY 2010 will be approximately $121MM. The company
has over 550 employees at two sites, Cambridge, Massachusetts and
Wilmington Ohio. As VP and General Manager of Manufacturing I managed 4
direct report Directors/Senior Managers and over 310 manufacturing,
quality, engineering/maintenance, development and various support personnel
supporting two commercial products, process development and clinical
manufacturing. The current portfolio of products is based on the
proprietary Medisorb Delivery Technology resulting in an extended release
Injectable product manufactured at the Wilmington Ohio plant.
. Responsible for plant operations, facilities engineering, maintenance,
safety, security, and technical support at Wilmington Ohio manufacturing
site. Technical advisor/liaison to partner (Amylin) site in West Chester,
Ohio.
. Consistently delivered increasing returns across the product portfolio
for the past 5 years.
. Managed annual expense budget of $100 million and capital budget in
excess averaging $20 million per year.
. Managed the continuous expansion of plant and office facilities to meet
strategic corporate goals and sales forecast. Over 100,000 sq. ft of new
construction and renovated space was completed on time and within budget.
. Collaborated on design and completed an 25,000 sq. ft. general office
expansion.
. Completed the construction of a 60,000 sq. ft. warehouse facility.
. Oversight of the construction of over 6,000 sq. ft. of new research and
development offices and laboratories.
. Directed an internal renovation of over 3,000 sq. ft. to replace outdated
areas of the existing facility.
. Created the infrastructure and organization to manage a >200% increase in
production volumes over 5 years. Plant output rose from just under 3
million doses to over 8 million doses in a 5 year period. Staff was
increased from approximately 100 direct labor, management and technical
support staff employees to over 300 direct labor, management and technical
support staff employees.
. Site named the External Manufacturer of the Year in 2007 by the Global
Pharmaceutical Supply Group of Janssen
. Oversight of Six Sigma and Lean Manufacturing programs for process
improvement and training
. Well established Safety and Quality Culture throughout the organization
. Created a manufacturing technical support function by initially devoting
a small staff focused upon process improvement, failure investigations,
validations and new product start-up/launch. The technical support group
was expanded over a period of approximately five years to also include
operational support of manufacturing automation/systems, Oracle
application support, operator skills training, and manufacturing
documentation.
. Increased operating efficiencies year after year by improved
manufacturing methods using Six Sigma tools, enhanced process technical
understanding and support, and enhanced operator training. Manufacturing
efficiency increased over 100% in five years. Manufacturing efficiencies
offset the impact of more complex processes and dosage forms as well as
the impact of smaller batch sizes.
. Leveraged plant capacity and a three shift, twenty-four hour seven day
operation to maximize capacity utilization and absorption of overtime.
. Received no 483 major observations in last 5 years. Three separate
biennial inspections by teams of FDA investigators, and performed as
systems based inspections, resulted in no observations. The latest
inspection was conducted in August 2008 and included the newly qualified
plant expansion.
. Responsible for the validation and manufacturing of launch quantities of
the company's first proprietary product in 2007.
. Initiated a risk management and business continuity programs for the
Wilmington manufacturing operations for the purpose of a major repair and
loss of manufacturing capabilities of the facility.
August 1980 - March 2004 Hoffmann-LaRoche Pharmaceutical
Nutley, NJ
Director of Parenteral Manufacturing Operations
. Responsible for plant operations in Nutley, NJ. Overall operations
consisted of approximately 45 total employees. Manufacturing encompassed,
sterile liquids and packaging operations for global distribution. A
significant portion of the operations was devoted to the launch of a new
AIDs product and dosage form production of Oncology products.
. Created departmental restructuring plan so that everyone was working
towards the same shared goal/endpoint and understood their current and
future roles and responsibilities
. Maintained critical cross functional working groups and relationships
with Quality, Engineering and Maintenance, Validation and Supply Chain
during launch planning
. Created a leadership team within the Parenteral manufacturing department
to establish priorities and deal with issues as they arose in a timely
manner
. Developed detailed plans for re-configuration of manufacturing operations
resulting in the downsizing of the Nutley Parenteral manufacturing
operations leading to its closing in 2006.
. Successfully sustained manufacturing operations through FDA, Canadian and
EU regulatory inspections without a major observations or interruption of
product supply
Director Antibiotic Manufacturing Operations
. Directed pharmaceutical manufacturing operations totaling 75,000 sq. ft.
and employing 85 people.
. Produced over 25 million units for distribution in the US supporting over
$600 Million in revenue
. Successfully salvaged an FDA inspection in progress that had taken a
negative tone and turned it into a favorable outcome
Various positions of increasing responsibility at Hoffmann-LaRoche
Director of Compliance and Technical Training
. Participated in the upgrade and creation of the quality systems required
by US and EXUS regulatory agencies.
. Responsible for batch card simplification and training
. Responsible for operator training programs for job function, FDA good
manufacturing practices and technical programs
Manager of Pharmaceutical Engineering and Maintenance
. Participated in the upgrade of the facilities to meet compliance for
global distribution of product from the Nutley site
. Created a maintenance management system in SAP
Business Process Leader
. Participated in the integration of Syntex products, facilities and
personnel following the acquisition by Hoffmann-LaRoche
. Participated on a cross functional team to improve product delivery and
obtain world class delivery as measured by order fulfillment and line fill
rate at the customer.
Facility 2001 Project Team Member
. Participated on a cross functional technical team to investigate new and
existing technologies for application in Pharmaceutical manufacturing
. Developed a design package for a modular facility and associated
utilities
Manager of Engineering
. Responsible for HVAC, High Pure Water and Production electronics and
instrumentation maintenance and operations
Senior Supervisor Sterile Manufacturing
. Participated in the design, construction, qualification and validation of
a multi floor 60000 square foot aseptic manufacturing facility
. Direct supervision of aseptic formulation, filling and inspections of
vials, syringes and ampoules manufactured in Nutley
August 1979 - August 1980 Warner Lambert Corp.
Morris Plains, NJ Supervisor
of Second Shift Operations
August 1976 - August 1979 Schering-Plough Corp.
Union, NJ
Manufacturing Chemist Sterile Operations
Education
BS Microbiology - Rutgers University 1976